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Introduction
The main limitation to a better knowledge of Autoin-
flammatory diseases is related to the extreme fragmenta-
tion of the diagnosed cases that are spread over different
centers and countries. The general aim of the Eurofever
Project (agreement n 2007332, EAHC) is to build an inter-
national registry on Autoinflammatory diseases.
Objectives
To evaluate the number of patients enrolled in the registry
in the first 36 months after starting the enrolment.
Methods
A web-based registry collecting baseline and cross-
sectional clinical information on Autoinflammatory dis-
eases is available in the member area of the PRINTO
web-site (www.printo.it). The registry is open to all
pediatric and adult Centers with a specific interest in
Autoinflammatory diseases. The following monogenic
autoinflammatory diseases were considered: Familial
Mediterranean Fever (FMF), Cryopyrin-associated peri-
odic syndromes (CAPS), TNF receptor-associated peri-
odic syndrome (TRAPS), mevalonate kinase deficiency
(MKD), Blau syndrome, pyogenic arthritis, pioderma
and acne (PAPA) syndrome, deficiency of IL-1 receptor
antagonist (DIRA), NLRP12-mediated periodic fever.
Information on CRMO, Behçet’s disease, PFAPA and
undefined periodic fevers were also collected.
Results
2721 patients, from 221 centers in 56 countries, have
been enrolled in the registry during the first 36 months.
Baseline demographic data (country of residence, disease
onset, disease duration, mutations, family history ect)
from all patients are now available. In 2213 (81%) com-
plete information on clinical manifestations and responses
to treatments is also available. The disease distribution of
enrolled patients is: FMF 787 (621 with complete clinical
data); TRAPS 237 (211 with with complete clinical data);
CAPS 207 (186 with complete clinical data); MKD 153
(133 with complete clinical data); Blau syndrome 62 (21
with complete clinical data); PAPA 19 (18 with complete
clinical data); NLRP-12 mediated periodic fever 8 (6 with
complete clinical data); DIRA and Majeed 3 and 2
patients, respectively (all with complete clinical data).
Among multifactorial autoinflammatory diseases: PFAPA
564 (402 with complete clinical data); CRMO 392 (370
with complete clinical data); pediatric Behçet disease 84
(68 with complete clinical data) and 205 patients with
undefined periodic fever (174 with complete clinical data).
Conclusion
A large registry of patients with Autoinflammatory dis-
eases is available and the enrolment is still ongoing. In the
next months novel inherited autoinflammatory diseases
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